1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Sweden >
  5. Stada Acquires Lobsor Pharmaceuticals

M&A Deal Summary

Stada Acquires Lobsor Pharmaceuticals

On October 2, 2020, Stada acquired life science company Lobsor Pharmaceuticals

Acquisition Highlights
  • This is Stada’s 6th transaction in the Life Science sector.
  • This is Stada’s 1st transaction in Sweden.

M&A Deal Summary
Date 2020-10-02
Target Lobsor Pharmaceuticals
Sector Life Science
Buyer(s) Stada
Deal Type Add-on Acquisition

Target

Lobsor Pharmaceuticals

Uppsala, Sweden
Lobsor Pharmaceuticals is a specialty pharmaceutical company focusing on innovative, proprietary technologies and drug formulations. Lobsor Pharmaceuticals was founded in 2013 and is based in Uppsala, Sweden.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Stada

Bad Vilbel, Germany
Category Company
Founded 1895
Sector Life Science
Employees10,435
Revenue 2.3B EUR (2018)
DESCRIPTION

Stada is a developer and marketer of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. Stada was founded in 1895 and is based in Bad Vilbel, Germany.

DEAL STATS #
Overall 11 of 11
Sector: Life Science M&A 6 of 6
Type: Add-on Acquisition M&A Deals 8 of 8
Country: Sweden M&A 1 of 1
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-24 GlaxoSmithKline - 15 Consumer Healthcare Brands

United Kingdom

GlaxoSmithKline plc's 15 Consumer Healthcare Brands develops and manufactures consumer healthcare products.

Buy -
Mergr

Solution for

Product

Company

Legal